These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 1446477)
41. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. FitzGerald JM; Boulet LP; Follows RM Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813 [TBL] [Abstract][Full Text] [Related]
42. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. Wallin A; Melander B; Rosenhall L; Sandström T; Wåhlander L Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599 [TBL] [Abstract][Full Text] [Related]
44. A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids. Tormey VJ; Faul J; Leonard C; Lennon A; Burke CM Ir J Med Sci; 1997; 166(4):249-52. PubMed ID: 9394077 [TBL] [Abstract][Full Text] [Related]
45. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Tattersfield AE; Löfdahl CG; Postma DS; Eivindson A; Schreurs AG; Rasidakis A; Ekström T Lancet; 2001 Jan; 357(9252):257-61. PubMed ID: 11214127 [TBL] [Abstract][Full Text] [Related]
46. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework. Dennis SM; Sharp SJ; Vickers MR; Frost CD; Crompton GK; Barnes PJ; Lee TH Lancet; 2000 May; 355(9216):1675-9. PubMed ID: 10905242 [TBL] [Abstract][Full Text] [Related]
47. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. van Essen-Zandvliet EE; Hughes MD; Waalkens HJ; Duiverman EJ; Pocock SJ; Kerrebijn KF Am Rev Respir Dis; 1992 Sep; 146(3):547-54. PubMed ID: 1355640 [TBL] [Abstract][Full Text] [Related]
48. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Juniper EF; Kline PA; Vanzieleghem MA; Ramsdale EH; O'Byrne PM; Hargreave FE Am Rev Respir Dis; 1990 Oct; 142(4):832-6. PubMed ID: 2221590 [TBL] [Abstract][Full Text] [Related]
49. Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible? van Schayck CP; van den Broek PJ; den Otter JJ; van Herwaarden CL; Molema J; van Weel C JAMA; 1995 Jul; 274(2):161-4. PubMed ID: 7596005 [TBL] [Abstract][Full Text] [Related]
50. A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma. Youngchaiyud P; Permpikul C; Suthamsmai T; Wong E Allergy; 1995 Jan; 50(1):28-33. PubMed ID: 7741186 [TBL] [Abstract][Full Text] [Related]
51. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators. van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720 [TBL] [Abstract][Full Text] [Related]
52. The effect of inhaled albuterol in moderate to severe asthma. Apter AJ; Reisine ST; Willard A; Clive J; Wells M; Metersky M; McNally D; ZuWallack RL J Allergy Clin Immunol; 1996 Aug; 98(2):295-301. PubMed ID: 8757206 [TBL] [Abstract][Full Text] [Related]
53. Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma. Willey RF; Godden DJ; Carmichael J; Preston P; Frame M; Crompton GK Br J Dis Chest; 1982 Jan; 76(1):61-8. PubMed ID: 7037035 [TBL] [Abstract][Full Text] [Related]
54. Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial. Papi A; Marku B; Scichilone N; Maestrelli P; Paggiaro P; Saetta M; Nava S; Folletti I; Bertorelli G; Bertacco S; Contoli M; Plebani M; Barbaro MPF; Spanevello A; Aliani M; Pannacci M; Morelli P; Beghé B; Fabbri LM; Lancet Respir Med; 2015 Feb; 3(2):109-119. PubMed ID: 25481378 [TBL] [Abstract][Full Text] [Related]
56. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. Dyer MJ; Halpin DM; Stein K BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053 [TBL] [Abstract][Full Text] [Related]
57. [How to make easier the treatment of asthma]. Ait-Khaled N Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S76-10S79. PubMed ID: 17127972 [No Abstract] [Full Text] [Related]
58. Do patients with COPD benefit from treatment with inhaled corticosteroids? van Schayck CP; van Grunsven PM; Dekhuijzen PN Eur Respir J; 1996 Oct; 9(10):1969-72. PubMed ID: 8902451 [No Abstract] [Full Text] [Related]
59. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Benbow AG; Naya IP Eur Respir J; 1994 Aug; 7(8):1554. PubMed ID: 7957846 [No Abstract] [Full Text] [Related]
60. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Markham A; Jarvis B Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]